“Sea Cucumbers” Discovered To Have Anticarcinogenic Substance
By Dialogo February 04, 2009QUE NOTICIA MARAVILHOSA Ã‰ ESSA!!!!
Que bom que podemos acreditar na cura do cancer
por meios satisfatorios.
Espero cinseramente que tudo de certo! , This is a good idea since number of cancer patients is increasing.. I have a question, "Do sea urchins also have anti-carcinogenic?" since they are closely related to sea cucumber, is it possible to sea urchins to have this factor?. Thank you so much for the article. I hope you can answer my question. God bless and more powers. Argentinean scientists discovered that the sea creatures known as “sea cucumbers” contain a substance capable of inhibiting the proliferation of cancer cells, local press reported today. The compound was found in “psolus patagonicus,” one of approximately 1,200 known species of “sea cucumber,” which is closely related to starfish and sea urchins and which roams the depths of the ocean, feeding on oceanic sediments. This discovery was the result of an interdisciplinary project financed by the National Scientific and Technical Research Council, the National Agency for Scientific and Technological Promotion, and the University of Buenos Aires. One of the authors of the investigation named the molecule “triterpeno glucósico” (TG), after proving that it is capable of inhibiting the proliferation of cancer cells obtained from human breast, liver, and lung tumors. TG is one of the defense mechanisms of the “sea cucumber.” When threatened, it excretes some of its viscera so that the predator is distracted with eating it, and at the same time expels substances toxic to some kinds of fish. A widely-known drawback of TG that has been obtained so far from different species of “sea cucumber” is that it damages all cells, whether normal or tumorous, making its utilization pharmacologically infeasible. Because of this, the researchers cautioned that there is a long way to go before these substances will have therapeutic applications on human beings, since numerous tests on laboratory animals will be necessary before clinical tests are approved.